Cargando…
HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?
Assessment of homologous recombination deficiency (HRD) status is now essential for ovarian cancer patient management. The aim of our study was to analyze the influence of ethnic variations, tumor purity, and neoadjuvant chemotherapy (CT) on the determination of HRD scores as well as to evaluate fea...
Autores principales: | Kekeeva, Tatiana, Andreeva, Yulia, Tanas, Alexander, Kalinkin, Alexey, Khokhlova, Svetlana, Tikhomirova, Tatiana, Tyulyandina, Alexandra, Popov, Anatoly, Kuzmenko, Maria, Volkonsky, Mikhail, Chernorubashkina, Natalia, Saevets, Valeria, Dmitriev, Vadim, Nechushkina, Valentina, Vedrova, Olga, Andreev, Sergei, Kutsev, Sergey, Strelnikov, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342032/ https://www.ncbi.nlm.nih.gov/pubmed/37445679 http://dx.doi.org/10.3390/ijms241310497 |
Ejemplares similares
-
Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer
por: Strelnikov, Vladimir V., et al.
Publicado: (2021) -
Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and its Relation to Epigenomic Subtypes and HER2 Overexpression
por: Simonova, Olga A., et al.
Publicado: (2020) -
Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing
por: Nemtsova, Marina V., et al.
Publicado: (2020) -
Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma
por: Alekseeva, Ekaterina A., et al.
Publicado: (2021) -
Implementing HRD technology /
Publicado: (1999)